Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
- PMID: 35657690
- PMCID: PMC9450567
- DOI: 10.2337/dbi22-0002
Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
Abstract
While the consumption of external energy (i.e., feeding) is essential to life, this action induces a temporary disturbance of homeostasis in an animal. A primary example of this effect is found in the regulation of glycemia. In the fasted state, stored energy is released to maintain physiological glycemic levels. Liver glycogen is liberated to glucose, glycerol and (glucogenic) amino acids are used to build new glucose molecules (i.e., gluconeogenesis), and fatty acids are oxidized to fuel long-term energetic demands. This regulation is driven primarily by the counterregulatory hormones epinephrine, growth hormone, cortisol, and glucagon. Conversely, feeding induces a rapid influx of diverse nutrients, including glucose, that disrupt homeostasis. Consistently, a host of hormonal and neural systems under the coordination of insulin are engaged in the transition from fasting to prandial states to reduce this disruption. The ultimate action of these systems is to appropriately store the newly acquired energy and to return to the homeostatic norm. Thus, at first glance it is tempting to assume that glucagon is solely antagonistic regarding the anabolic effects of insulin. We have been intrigued by the role of glucagon in the prandial transition and have attempted to delineate its role as beneficial or inhibitory to glycemic control. The following review highlights this long-known yet poorly understood hormone.
© 2022 by the American Diabetes Association.
Figures



Similar articles
-
Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat.Metabolism. 2022 Nov;136:155310. doi: 10.1016/j.metabol.2022.155310. Epub 2022 Sep 3. Metabolism. 2022. PMID: 36063868
-
PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4285-4290. doi: 10.1073/pnas.1815150116. Epub 2019 Feb 15. Proc Natl Acad Sci U S A. 2019. PMID: 30770439 Free PMC article.
-
Physiologic action of glucagon on liver glucose metabolism.Diabetes Obes Metab. 2011 Oct;13 Suppl 1(Suppl 1):118-25. doi: 10.1111/j.1463-1326.2011.01454.x. Diabetes Obes Metab. 2011. PMID: 21824265 Free PMC article. Review.
-
Glucagon in glucose homeostasis and metabolic disease: from physiology to therapeutics.J Basic Clin Physiol Pharmacol. 2025 May 5;36(2-3):139-146. doi: 10.1515/jbcpp-2025-0005. eCollection 2025 Mar 1. J Basic Clin Physiol Pharmacol. 2025. PMID: 40314189 Review.
-
[Glucagon and glucagon-like peptides the role in control glucose homeostasis. Part I].Pediatr Endocrinol Diabetes Metab. 2011;17(4):215-21. Pediatr Endocrinol Diabetes Metab. 2011. PMID: 22248782 Review. Polish.
Cited by
-
Liver Injury and Metabolic Dysregulation in Largemouth Bass (Micropterus salmoides) after Ammonia Exposure.Metabolites. 2023 Feb 14;13(2):274. doi: 10.3390/metabo13020274. Metabolites. 2023. PMID: 36837893 Free PMC article.
-
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice.Nat Commun. 2025 May 21;16(1):4714. doi: 10.1038/s41467-025-59773-4. Nat Commun. 2025. PMID: 40399267 Free PMC article.
-
From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity.Endocr Connect. 2024 Apr 25;13(5):e230529. doi: 10.1530/EC-23-0529. Print 2024 May 1. Endocr Connect. 2024. PMID: 38579770 Free PMC article. Review.
-
Adaptive Effects of Endocrine Hormones on Metabolism of Macronutrients during Fasting and Starvation: A Scoping Review.Metabolites. 2024 Jun 16;14(6):336. doi: 10.3390/metabo14060336. Metabolites. 2024. PMID: 38921471 Free PMC article.
-
Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog.Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E428-E442. doi: 10.1152/ajpendo.00316.2023. Epub 2024 Feb 7. Am J Physiol Endocrinol Metab. 2024. PMID: 38324258 Free PMC article.
References
-
- Banting FG, Best CH. The internal secretions of the pancreas. J Lab Clin Med 1922;5:251–266 - PubMed
-
- Kimball CP, Murlin JR. Aqueous extracts of pancreas. III. Some precipitation reactions of insulin. J Biol Chem 1923;58:337–346
-
- Murlin JR, Clough HD, Gibbs CBF, Stokes AM. Aqueous extracts of the pancreas. I. Influence on the carbohydrate metabolism of depancreatized animals. J Biol Chem 1923;56:253–296
-
- Bürger M, Brandt W. Über das glukagon (die hyperglykämisierende substanz des pankreas). Z Gesamte Exp Med 1935;96:375
-
- Bürger M, Kramer H. Über den hepatischen angriffspunkt des insulins. Z Gesamte Exp Med 1929;65:487–497
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical